Drug intelligence / Profile preview

EmbryoFix Granules

Development stage
Unknown
Lead developer
MMC Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

EmbryoFix Granules is a multi-ingredient nutraceutical supplement developed by MMC Pharmaceuticals, specifically formulated for use in gynecology and fertility management. The product is primarily indicated for improving endometrial thickness and receptivity in women experiencing infertility or recurrent pregnancy loss. Its formulation typically includes L-arginine, lycopene, folic acid, and a complex of essential vitamins (B6, B12) and minerals (Zinc, Selenium). The primary mechanism of action is driven by L-arginine, which serves as a precursor for nitric oxide (NO) production. Nitric oxide acts as a potent vasodilator, enhancing blood flow to the uterus and ovaries, which in turn supports the development of a healthy endometrial lining suitable for embryo implantation. Additionally, antioxidants like lycopene and selenium help mitigate oxidative stress in the reproductive environment.

Brand names
EmbryoFix Granules
Other names
EmbryoFix
02

Targets

NOS1 (nNOS)

Beyond the preview

Go deeper on EmbryoFix Granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on EmbryoFix Granules.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call